Teligent Cost of Goods Sold 2010-2021 | TLGT
Teligent cost of goods sold from 2010 to 2021. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Teligent Annual Cost of Goods Sold
(Millions of US $) |
| 2020 |
$49 |
| 2019 |
$42 |
| 2018 |
$43 |
| 2017 |
$33 |
| 2016 |
$28 |
| 2015 |
$23 |
| 2014 |
$17 |
| 2013 |
$12 |
| 2012 |
$6 |
| 2011 |
$6 |
| 2010 |
$5 |
| 2009 |
$4 |
Teligent Quarterly Cost of Goods Sold
(Millions of US $) |
| 2021-06-30 |
$13 |
| 2021-03-31 |
$13 |
| 2020-12-31 |
$15 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$11 |
| 2020-03-31 |
$9 |
| 2019-12-31 |
$14 |
| 2019-09-30 |
$11 |
| 2019-06-30 |
$10 |
| 2019-03-31 |
$7 |
| 2018-12-31 |
$11 |
| 2018-09-30 |
$12 |
| 2018-06-30 |
$11 |
| 2018-03-31 |
$9 |
| 2017-12-31 |
$7 |
| 2017-09-30 |
$9 |
| 2017-06-30 |
$8 |
| 2017-03-31 |
$9 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$8 |
| 2016-06-30 |
$8 |
| 2016-03-31 |
$8 |
| 2015-12-31 |
$7 |
| 2015-09-30 |
$6 |
| 2015-06-30 |
$5 |
| 2015-03-31 |
$5 |
| 2014-12-31 |
$5 |
| 2014-09-30 |
$4 |
| 2014-06-30 |
$4 |
| 2014-03-31 |
$4 |
| 2013-12-31 |
$4 |
| 2013-09-30 |
$3 |
| 2013-06-30 |
$3 |
| 2013-03-31 |
$3 |
| 2012-12-31 |
$2 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$2 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
